[go: up one dir, main page]

MX9302711A - Preparacion de base. - Google Patents

Preparacion de base.

Info

Publication number
MX9302711A
MX9302711A MX9302711A MX9302711A MX9302711A MX 9302711 A MX9302711 A MX 9302711A MX 9302711 A MX9302711 A MX 9302711A MX 9302711 A MX9302711 A MX 9302711A MX 9302711 A MX9302711 A MX 9302711A
Authority
MX
Mexico
Prior art keywords
dibenz
tetrahydro
trans
chloro
methyl
Prior art date
Application number
MX9302711A
Other languages
English (en)
Inventor
Petrus Johannes Maria Oetelaar
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of MX9302711A publication Critical patent/MX9302711A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describe la sal de hemipatoato y pamoato de trans-5-cloro-2-metil-2, 3, 3, 3a, 12b-tetrahidro-1h-dibenz(2, 3; 6, 7)oxepino-(4, 5-c)pirrol, compuestos muy insolubles que tienen excelentes propiedades para utilizarse como preparaciones base. También se describen preparaciones farmacéuticas que incluyen a las sales de pamoato de trans-5-cloro-2-metil-2, 3, 3a, 12b-tetrahidro-1H-dibenz(2, 3; 6,/)oxepino-(4, 5-c)pirrol, especialmente en forma cristalina. Estas preparaciones liberan cantidades terapéuticamente útiles de trans-5-cloro-2-metil-2, 3, 3a, 12b-tetrahidro-1H-dibenz(2, 3; 6, 7) oxepino-(4, 5-c)pirrol durante 2 a 6 semanas después de la administración.
MX9302711A 1992-05-08 1993-05-07 Preparacion de base. MX9302711A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92201319 1992-05-08

Publications (1)

Publication Number Publication Date
MX9302711A true MX9302711A (es) 1994-05-31

Family

ID=8210598

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302711A MX9302711A (es) 1992-05-08 1993-05-07 Preparacion de base.

Country Status (8)

Country Link
JP (1) JPH0656840A (es)
KR (1) KR930023338A (es)
AU (1) AU3846293A (es)
CA (1) CA2095499A1 (es)
FI (1) FI932088A (es)
MX (1) MX9302711A (es)
NO (1) NO931671L (es)
ZA (1) ZA933134B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2139051C1 (ru) * 1994-03-02 1999-10-10 Акцо Нобель Н.В. Сублингвальная или трансбуккальная фармацевтическая композиция
ES2221376T3 (es) * 1998-09-30 2004-12-16 ELI LILLY & COMPANY Formulacion de 2-metil-tieno-benzodiazepina.
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
GB0216416D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
CA2766291C (en) * 2009-06-24 2016-06-21 Msd Oss B.V. Injectable formulations containing asenapine and method of treatment using same
JP2021014404A (ja) * 2017-10-13 2021-02-12 アステラス製薬株式会社 トリアゾロピラジン誘導体の塩及び結晶

Also Published As

Publication number Publication date
NO931671L (no) 1993-11-09
NO931671D0 (no) 1993-05-07
KR930023338A (ko) 1993-12-18
FI932088A0 (fi) 1993-05-07
FI932088A (fi) 1993-11-09
ZA933134B (en) 1993-11-30
CA2095499A1 (en) 1993-11-09
AU3846293A (en) 1993-11-11
JPH0656840A (ja) 1994-03-01

Similar Documents

Publication Publication Date Title
ES2074124T5 (es) Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal.
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
ES2032009T3 (es) Procedimiento para preparar complejos estables de interferon.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
DK0605484T3 (da) Peptider med væksthormonfrigørende aktivitet
AR218037A1 (es) Procedimiento para preparar un sistema terapeutico en la forma de un parche cutaneo para la administracion de la droga clonidina
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
MX9201672A (es) Compuesto de pirazol piridina y procedimiento para la preparacion de los mismos.
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
ES2066062T3 (es) Preparacion de liberacion sostenida para administracion al cerebro.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
GB1321509A (en) Azepine derivatives
MX9302711A (es) Preparacion de base.
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
FR2407928A1 (fr) Derives de quinazoline utiles comme medicaments antihypertenseurs et procede de leur preparation
FR2351942A1 (fr) Derives d'acide acetyl-3 dimethyl-2,2 cyclopropanecarboxylique utilisables dans la preparation d'insecticides
GB2000025A (en) Nitroimidazole formulations
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
SE8004383L (sv) Farmaceutisk beredning for oral administrering och forfarande for dess framstellning
SE8204792L (sv) N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt
ES2043736T3 (es) Acidos 3,5-dihidroxi-heptanoicos sustituidos con (1h-pirrol-3-ilo) en posicion 7, sus correspondientes delta-lactonas y sales, procedimientos para su preparacion, su utilizacion como medicamentos, preparados farmaceuticos y productos intermedios.
FI880027A (fi) Antibakteriellt lyofiliserat preparat.